Related Experiment Video
Updated: May 27, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Insomnia in relation to 10 urological and reproductive conditions: a two-sample Mendelian randomization study
Yougen Wu1,2, Yang Wang3, Wei Wang3
1Clinical Trial Institution, Fifth People's Hospital of Shanghai Fudan University, Shanghai, China.
Background:
The causal association of insomnia with multiple urological and reproductive conditions still lacks clarity. Our aim was to assess this relationship by examining impact of insomnia on 10 urological and reproductive conditions using Mendelian randomization (MR) designs.
Methods:
Summary statistics for insomnia and 10 urological and reproductive conditions were acquired from the UK Biobank, 23andMe, FinnGen, and genetic consortia. Inverse variance weighted approach was utilized as the main MR analysis. Sensitivity analyses were performed employing MR-PRESSO (Pleiotropy Residual Sum and Outlier), maximum likelihood, MR-Egger, and weighted median methods to examine the robustness of the estimates.
Results:
Genetically determined insomnia showed an elevated risk of cystitis [odds ratio (OR) =1.81; 95% confidence interval (CI): 1.47-2.24; P<0.001], and prostatitis (OR =3.53; 95% CI: 1.73-7.18; P<0.001) after Bonferroni correction. Suggestive evidence of an association was found between insomnia and a heightened risk of prostate cancer (OR =1.30; 95% CI: 1.00-1.67; P=0.046), alongside a decreased risk of bladder cancer (OR =0.48; 95% CI: 0.26-0.90; P=0.02). No causal effects were observed for kidney cancer, kidney and ureter calculus, neurogenic bladder, benign prostatic hyperplasia (BPH), male infertility, or female infertility.
Conclusions:
Findings support insomnia as a potential causal risk factor for cystitis and prostatitis. This highlights insomnia as an important target for reducing the risk of these diseases.
More Related Videos
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Regression Toward the Mean
Blind Procedures
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....